IDO-1 blockade alone rescued only CD4+ T cells (figure 5F, G group D (PC3 tumor+T cells+IFN-γ+anti-IDO-1)), suggesting that PD-L1 could still damage CD8+ T and NKT cells. Here, IDO1 is linked to neoplasm.